isoborneol has been researched along with 3,4-dihydroxyphenyllactic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, J; Cui, H; Li, Z; Liu, X; Luan, L; Sun, D; Yang, H | 1 |
| Fei, F; Sun, H; Xiao, C; Yuan, X; Zhang, Y; Zhao, X; Zheng, X | 1 |
2 other study(ies) available for isoborneol and 3,4-dihydroxyphenyllactic acid
| Article | Year |
|---|---|
Effect of borneol on the distribution of danshensu to the eye in rabbit via oral administration.
Topics: Administration, Oral; Animals; Aqueous Humor; Biological Availability; Biological Transport; Blood-Aqueous Barrier; Blood-Retinal Barrier; Camphanes; Chromatography, High Pressure Liquid; Cornea; Drugs, Chinese Herbal; Female; Lactates; Male; Rabbits; Vitreous Body | 2010 |
Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.
Topics: Animals; Antioxidants; Brain; Camphanes; Drug Carriers; Drug Liberation; Drug Stability; Half-Life; Lactates; Lipids; Male; Mice, Inbred C57BL; Nanostructures; Particle Size; Polyethylene Glycols; Rats, Sprague-Dawley; Solubility | 2018 |